Genzyme and Isis report updated mipomersen results, as firms prepare for filings
07 April 2011
Donna Young
Please Login to read the full article.
07 April 2011
Donna Young
donna.young@informa
Please Login to read the full article.
RELATED CONTENT
NEWS
- Genzyme and ISIS submit first filing for mipomersenin EU to treat FH
- Aegerion expects to file in US, Europe by year end for lomitapide for rare lipid disorder
- Aergerion pushes back US, EU filings until 2012 for lomitapide to gather stability data
- US FDA accepts Aegerion NDA for HoFH drug
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
